Inflammatory bowel diseases and Parkinson's disease
Open accessThe DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Abstract
The etiology of Parkinson’s disease (PD) is multifactorial, with genetics, aging, and environmental agents all a part of the PD pathogenesis. Widespread aggregation of the α-synuclein protein in the form of Lewy bodies and Lewy neurites, and degeneration of substantia nigra dopamine neurons are the pathological hallmarks of PD. Inflammatory responses manifested by glial reactions, T cell infiltration, and increased expression of inflammatory cytokines, as well as other toxic mediators derived from activated glial cells, are currently recognized as prominent features of PD. Experimental, clinical and epidemiological data suggest that intestinal inflammation contributes to the pathogenesis of PD, and the increasing number of studies suggests that the condition may start in the gastrointestinal system years before any motor symptoms develop. Patients with inflammatory bowel disease (IBD) have a higher risk of developing PD compared with non-IBD individuals. Gene association study has found a genetic link between IBD and PD, and an evidence from animal studies suggests that gut inflammation, similar to that observed in IBD, may induce loss of dopaminergic neurons. Based on preclinical models of PD, it is suggested that the enteric microbiome changes early in PD, and gut infections trigger α-synuclein release and aggregation. In this paper, the possible link between IBD and PD is reviewed based on the available literature. Given the potentially critical role of gastrointestinal pathology in PD pathogenesis, there is reason to suspect that IBD or its treatments may impact PD risk. Thus, clinicians should be aware of PD symptoms in IBD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies have shown that patients with inflammatory bowel diseases have a higher risk of Parkinson's disease.”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [98]
The cited source says what the claim attributes to it.
In the citing paper
“In autoimmune conditions, peripheral inflammation caused by gut inflammation may trigger a-synuclein aggregation, increasing the permeability of intestinal tract and BBB and leading to neuroinflammation.98”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [98]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, inflammatory bowel diseases and Parkinson's disease share some common genetic factors.98”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“a pathway to spread the pathological protein to the 636 brain according to the Braak’s theory [5, 131].”
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“In fact, neurochemical and behavioral effects were not present in vagotomized mice, identifying the vagus as the major modulatory constitutive communication pathway between microbiota and the brain [128].”
BackgroundGut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712 · cited 1×
“The major 92 symptoms of UC are diarrhea, rectal bleeding, tenes93 mus, passage of mucus, and crampy abdominal pain 94 [20].”
BackgroundCytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Research works printed but not linked: 5
- Machado A, 2011, Adv Neurol, 2011, 393769
- Villumsen M, 2018, Gut, 68, 1722
- Grathwohl S, 2019, bioRxiv, 505164
- Carabotti M, 2015, Ann Gastroenterol, 28, 203
- Berge N, 2019, Acta Neuropathol
Cited by
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 380
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Harms, A. S., Ferreira, S. A., & Romero-Ramos, M. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02268-5 · Cited by 272
The Association Between the Gut Microbiota and Parkinson’s Disease, a Meta-Analysis
Shen, T., Yue, Y., He, T., Huang, C., Qu, B., Lv, W., & Lai, H.-Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.636545 · Cited by 219
“Higher susceptibility to PD was observed when intestinal infection existed (Huang et al., 2018; Brudek, 2019), which might trigger PD-like symptoms (Matheoud et al.”
BackgroundParkinson's Disease: A Multisystem Disorder
Costa, H. N., Esteves, A. R., Empadinhas, N., & Cardoso, S. M. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-00934-6 · Cited by 181
The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
Jan, A., Gonçalves, N. P., Vægter, C. B., Jensen, P. H., & Ferreira, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158338 · Cited by 144
Central role of microglia in sepsis-associated encephalopathy: From mechanism to therapy
Yan, X., Yang, K., Xiao, Q., Hou, R., Pan, X., & Zhu, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.929316 · Cited by 121
Yip, J. L. K., Balasuriya, G. K., Spencer, S. J., & Hill‐Yardin, E. L. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.021 · Cited by 143
Talley, S., Valiauga, R., Anderson, L., Cannon, A. R., Choudhry, M. A., & Campbell, E. M. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02317-6 · Cited by 106
Xiang, Z.-B., Xu, R.-S., Zhu, Y., Yuan, M., Liu, Y., Yang, F., Chen, W.-Z., & Xu, Z.-Z. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.317981 · Cited by 93
Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
Alam, M. M., Yang, D., Li, X.-Q., Liu, J., Back, T. C., Trivett, A., Karim, B., Barbut, D., Zasloff, M., & Oppenheim, J. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110090 · Cited by 91
Bellucci, A., Bubacco, L., Longhena, F., Parrella, E., Faustini, G., Porrini, V., Bono, F., Missale, C., & Pizzi, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00068 · Cited by 84
Peng, K., Xia, S., Xiao, S., & Yu, Q. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15970 · Cited by 85
Intestinal Inflammation and Parkinson’s Disease
Li, Y., Chen, Y., Jiang, L., Zhang, J., Tong, X., Chen, D., & Le, W. (2021) · Aging and Disease · doi:10.14336/ad.2021.0418 · Cited by 80
Farmen, K., Tofiño-Vian, M., & Iovino, F. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.680858 · Cited by 76
Matisz, C. E., & Gruber, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.020 · Cited by 74
Konings, B., Villatoro, L. G., den Eynde, J. V., Barahona, G. A., Burns, R., McKnight, M., Hui, K. Y., Yenokyan, G., Tack, J. F., & Pasricha, P. J. (2023) · Gut · doi:10.1136/gutjnl-2023-329685 · Cited by 67
New hope for Parkinson’s disease treatment: Targeting gut microbiota
Fan, H., Sheng, S., & Zhang, F. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13916 · Cited by 66
Hong, C., Chan, L., Chen, K., Lee, H., Huang, L., Yang, Y. S. H., Liu, Y., & Hu, C. (2022) · Cells · doi:10.3390/cells11213468 · Cited by 60
Inflammatory bowel disease induces pathological α‐synuclein aggregation in the human gut and brain
Espinosa‐Oliva, A. M., Ruiz, R., Soto, M. S., Boza‐Serrano, A., Rodriguez-Perez, A. I., Roca-Ceballos, M. A., García‐Revilla, J., Santiago, M., Serres, S., Economopoulus, V., et al. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12962 · Cited by 59
Inflammatory Bowel Disease and Neurodegenerative Diseases
Kim, J. S., Chen, M., Wang, H. E., Lu, C., Wang, Y., & Zhang, B. (2023) · Gut and Liver · doi:10.5009/gnl220523 · Cited by 57
Fucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases
Hu, M., Zhang, X., Li, J., Chen, L., He, X., & Sui, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.940196 · Cited by 52
Microbiome-based therapies for Parkinson’s disease
Alam, M., Abbas, K., Mustafa, M., Usmani, N., & Habib, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1496616 · Cited by 50
Selvakumar, B., & Samsudin, A. R. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf225 · Cited by 50
The role of the brain renin-angiotensin system in Parkinson´s disease
Labandeira-García, J. L., Labandeira, C. M., Guerra, M. J., & Rodriguez-Perez, A. I. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00410-3 · Cited by 50
Vitexin Protects against Dextran Sodium Sulfate-Induced Colitis in Mice and Its Potential Mechanisms
Zhang, J., Liang, F., Chen, Z., Chen, Y., Yuan, J., Xiong, Q., Hou, S., Huang, S. M., Liu, C., & Liang, J. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05177 · Cited by 48
Aghamohammad, S., Hafezi, A., & Rohani, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114816 · Cited by 48
Chui, Z. S. W., Chan, L. M. L., Zhang, E. W. H., Liang, S., Choi, E. P. H., Lok, K. Y. W., Tun, H. M., & Kwok, J. Y. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-59250-w · Cited by 47
Aggarwal, M., Alkhayyat, M. M., Saleh, M. A., Sarmini, M. T., Singh, A., Garg, R., Garg, P., Mansoor, E., Padival, R., & Cohen, B. L. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001714 · Cited by 46
Li, S., Bi, G., Han, S., & Huang, R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.744942 · Cited by 45
“Activated MG slowly releases pro-inflammatory cytokines, leading to the degeneration of dopaminergic neurons (Brudek, 2019).”
BackgroundLi, Q., Meng, L., Chen, L., Shi, X., Tu, L., Zhou, Q. G., Yu, J.-L., Liao, X., Zeng, Y., & Yuan, Q. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1185375 · Cited by 45
Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials
Hong, C., Chen, J., & Huang, T. (2022) · Aging · doi:10.18632/aging.204266 · Cited by 45
Li, T., Jing, H., Gao, X., Zhang, T.-S., Yao, H., Zhang, X., & Zhang, M. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06531-1 · Cited by 44
Zhu, Y., Li, Y., Zhang, Q., Song, Y., Wang, L., & Zhu, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.798917 · Cited by 44
Cui, G., Li, S., Ye, H., Yang, Y., Huang, Q., Chu, Y., Shi, Z., & Zhang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956005 · Cited by 44
Chan, L., Chung, C., Chen, J., Yu, R., & Hong, C. (2021) · Cells · doi:10.3390/cells10030604 · Cited by 43
Neurobiological findings underlying depressive behavior in Parkinson’s disease: A review
Mendonça, I. P., Duarte-Silva, E. P., Chaves-Filho, A. J. M., Andrade‐da‐Costa, B. L. D. S., & Peixoto, C. A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106434 · Cited by 42
Inflammatory Animal Models of Parkinson’s Disease
García‐Revilla, J., Herrera, A. J., de Pablos, R. M., & Venero, J. L. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-213138 · Cited by 40
Genetic overlap between Parkinson’s disease and inflammatory bowel disease
Kang, X., Ploner, A., Wang, Y., Ludvigsson, J. F., Williams, D. M., Pedersen, N. L., & Wirdefeldt, K. (2022) · Brain Communications · doi:10.1093/braincomms/fcad002 · Cited by 39
Liebert, A. D., Bicknell, B. T., Laakso, E., Jalilitabaei, P., Tilley, S., Kiat, H., & Mitrofanis, J. (2021) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1089/photob.2021.0056 · Cited by 38
Bicknell, B. T., Liebert, A. D., McLachlan, C. S., & Kiat, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010049 · Cited by 38
Epidemiology of Parkinson’s disease
Катунина, Е. А., Putyatin, I. A., Dzugaeva, F. K., & Batsoeva, D. O. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512511239 · Cited by 37
Yeung, S. S.-H., Ho, J. Y. S., & Chang, R. C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00660-5 · Cited by 36
Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
Chao, Y., Gulam, M. Y., Chia, N. S. J., Feng, L., Rötzschke, O., & Tan, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00849 · Cited by 35
PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases
Pap, D., Veres-Székely, A., Szebeni, B., & Vannay, Á. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126626 · Cited by 34
Naik, B., Sasikumar, J., & Das, S. P. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04270-w · Cited by 33
Li, H., Zhang, C., Zhang, K., Liu, Y.-Z., Peng, X., & Zong, Q. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1137366 · Cited by 32
Yang, X., Zhang, X., Ma, Y., Li, S., Wang, Q., Hong, J., Yu, G., Qi, B., Wang, J., Liu, C., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137373 · Cited by 31
The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease
Yang, R., Gao, G., & Yang, H. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.861035 · Cited by 31
Towards early detection of neurodegenerative diseases: A gut feeling
Makdissi, S., Parsons, B., & Cara, F. D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1087091 · Cited by 31
Altered Gut Microbiota in Parkinson’s Disease Patients with Motor Complications
Takahashi, K., Nishiwaki, H., Ito, M., Iwaoka, K., Takahashi, K., Suzuki, Y., Taguchi, K., Yamahara, K., Tsuboi, Y., Kashihara, K., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.12.012 · Cited by 29
Chalazonitis, A., Rao, M., & Sulzer, D. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00308-9 · Cited by 29
Inflammatory Bowel Disease and Patients With Mental Disorders: What Do We Know?
Fousekis, F. S., Katsanos, A. H., Kourtis, G., Saridi, M., Albani, E., Katsanos, K. H., & Christodoulou, D. K. (2021) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4593 · Cited by 28
New Insights and Implications of Natural Killer Cells in Parkinson’s Disease
Menees, K. B., & Lee, J. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223212 · Cited by 29
Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism
Chittoor-Vinod, V. G., Nichols, R. J., & Schüle, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031045 · Cited by 28
Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study
Sun, Y., Geng, J., Chen, X., Chen, H., Wang, X., Chen, J., Li, X., & Hesketh, T. M. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab300 · Cited by 28
Kulminski, A. M., Loiko, E., Loika, Y., & Culminskaya, I. V. (2021) · GeroScience · doi:10.1007/s11357-021-00484-1 · Cited by 27
James, D. M., Davidson, E. A., Yanes, J. A., Moshiree, B., & Dallman, J. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.662916 · Cited by 26
Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach
Forero-Rodríguez, L. J., Josephs‐Spaulding, J., Flor, S., Pinzón, A. M., & Kaleta, C. (2021) · Antioxidants · doi:10.3390/antiox11010071 · Cited by 26
Lipopolysaccharide mouse models for Parkinson’s disease research: a critical appraisal
Bobrovskaya, L., & Deng, I. B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.331866 · Cited by 25
Rapa, S. F., Paola, R. D., Cordaro, M., Siracusa, R., D’Amico, R., Fusco, R., Autore, G., Cuzzocrea, S., Stuppner, H., & Marzocco, S. (2021) · Biomedicines · doi:10.3390/biomedicines9010067 · Cited by 24
Unveiling the therapeutic potential and mechanism of inulin in DSS-induced colitis mice
Niu, B., Li, F., Lv, X., Xiao, Y., Zhu, J., Zhao, J., Lu, W., & Chen, W. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135861 · Cited by 24
Passive Immunization in Alpha-Synuclein Preclinical Animal Models
Folke, J., Ferreira, N., Brudek, T., Borghammer, P., & Berge, N. V. D. (2022) · Biomolecules · doi:10.3390/biom12020168 · Cited by 24
Self-citationLuo, Q., Zhou, P., Chang, S., Huang, Z., & Zhu, Y. (2023) · Heart & Lung · doi:10.1016/j.hrtlng.2023.05.016 · Cited by 22
New Role of the Serotonin as a Biomarker of Gut–Brain Interaction
Liu, H. N., Nakamura, M., & Kawashima, H. (2024) · Life · doi:10.3390/life14101280 · Cited by 23
Sheikhpour, E., Mard, S. A., Farbood, Y., Bavarsad, K., & Sarkaki, A. (2023) · Life Sciences · doi:10.1016/j.lfs.2022.121356 · Cited by 21
Immunity orchestrates a bridge in gut-brain axis of neurodegenerative diseases
Cheng, Y., Chen, C., & Zhang, F. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101857 · Cited by 21
Zong, J., Yang, Y. X., Wang, H., Zhang, H., Yang, X., & Yang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1325908 · Cited by 20
Jellinger, K. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072942 · Cited by 20
Guo, M., Gao, H., Wang, Y., & Xiang, Y. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1574512 · Cited by 19
Bačelis, J., Compagno, M., George, S., Pospisilik, J. A., Brundin, P., Naluai, Å. T., & Brundin, L. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202418 · Cited by 18
Yang, Y., ding, T., Xiao, G., Huang, J., Luo, D., Yue, M., Su, Y., Jiang, S., Zeng, J., & Liu, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11020464 · Cited by 18
The role of gut-brain axis in a rotenone-induced rat model of Parkinson's disease.
Santos, J. C. D. D., da Silva, M. R. C., Oliveira, L. F., Cardoso, F. D. S., Nascimento, T. D. S., Oliveira, A. V., Lima, M. P. P., de Andrade, G. M., Brito, G. A. D. C., & Viana, G. S. D. B. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.07.005 · Cited by 10
Chen, M., Zhang, Y., Hou, L., Zhao, Z., Tang, P., Sun, Q., Zhao, J., & Wang, Q. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00892-6 · Cited by 17
Data-driven comparison of multiple high-dimensional single-cell expression profiles
Okada, D., Cheng, J. H., Zheng, C., & Yamada, R. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00989-9 · Cited by 16
CXCR4 as possible druggable target linking inflammatory bowel disease and Parkinson's disease
Dogra, N., Mani, R. J., Potshangbam, A. M., Buch, S. J., & Katare, D. P. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-022-01155-6 · Cited by 16
Ma, W., Lian, L., Guo, L., Wu, Y., & Huang, L. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1582155 · Cited by 15
Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease
Yan, Z., Li, R., Shi, W., & Yao, L. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01004-6 · Cited by 15
Neuroprotection by Abdominal Ultrasound in Lipopolysaccharide-Induced Systemic Inflammation
Song, W.-S., Hung, T., Liu, S., Zheng, Y., Lin, H.-M., & Yang, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119329 · Cited by 15
Niu, B., Gao, W., Li, F., Pei, Z., Wang, H., Tian, F., Zhao, J., & Lu, W. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.142544 · Cited by 14
Espinosa‐Oliva, A. M., García‐Miranda, P., Alonso-Bellido, I. M., Carvajal, A. E., González-Rodríguez, M., Carrillo-Jiménez, A., Temblador, A., Felices-Navarro, M., García-Domínguez, I., Roca-Ceballos, M. A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.706439 · Cited by 14
Cytokine profiles of plasma extracellular vesicles as progression biomarkers in Parkinson’s disease
Chan, L., Chung, C., Yu, R., & Hong, C. (2023) · Aging · doi:10.18632/aging.204575 · Cited by 14
Gonçalves, A. M. R., Pereira-Santos, A. R., Esteves, A. R., Cardoso, S. M., & Empadinhas, N. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7997 · Cited by 14
Yang, W., Xu, S., Zhou, M., & Chan, P. (2024) · Aging · doi:10.18632/aging.205954 · Cited by 12
Morais, L. H., Stiles, L., Freeman, M., Oguienko, A. D., Hoang, J. D., Ji, J., Jones, J. J., Quan, B., Devine, J., Bois, J. S., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01142-5 · Cited by 10
Gut Microbiota Dynamics in Parkinsonian Mice
Klann, E. M., Tagliamonte, M. S., Ukhanova, M., Mai, V., & Vedam‐Mai, V. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00386 · Cited by 10
Luo, Q., Wang, J., Ge, W., Li, Z., Mao, Y., Wang, C., & Zhang, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28944 · Cited by 10
Xu, X., Wei, S., Lin, M., Chen, F., Zhang, X., & Zhu, Y. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2440602 · Cited by 10
The role of gut-derived short-chain fatty acids in Parkinson's disease
Saadh, M. J., Mustafa, A. N., Mustafa, M. A., Renuka Jyothi, S., Dabis, H. K., Prasad, G. V. S., Mohammad, I. J., Adnan, A., & Idan, A. H. (2024) · Neurogenetics · doi:10.1007/s10048-024-00779-3 · Cited by 9
Etiology and pathogenesis of Parkinson disease
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00005-6 · Cited by 9
Loosen, S. H., Yaqubi, K., May, P., Konrad, M., Gollop, C., Luedde, T., Kostev, K., & Roderburg, C. (2023) · Life · doi:10.3390/life13040897 · Cited by 9
Microorganisms associated with increased risk of Parkinson’s disease
Fernández‐Espejo, E. (2022) · Neurología (English Edition) · doi:10.1016/j.nrleng.2020.08.023 · Cited by 9
Parkinson’s disease: epidemiology and pathogenesis
Borozdenko, D. A., Bogorodova, V. I., Kiseleva, N. M., & Negrebetsky, V. V. (2021) · Russian Medicine · doi:10.17816/0869-2106-2021-27-2-183-194 · Cited by 8
Schirinzi, T., Grillo, P., & Basilicata, M. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335820 · Cited by 8
Liao, O., Xie, S., Ye, J., Du, Q., & Lou, G. (2024) · World Journal of Psychiatry · doi:10.5498/wjp.v14.i1.15 · Cited by 8
Microorganismos relacionados con un mayor riesgo de presentar la enfermedad de Parkinson
Fernández‐Espejo, E. (2020) · Neurología · doi:10.1016/j.nrl.2020.08.020 · Cited by 7
dos Santos, J. C. C., de Aquino, P. E. A., Martins, C. S., Sallem, C. C., Guizardi, M. P. P., Noleto, F. M., Zampieri, D., Ricardo, N. M. P. S., de Brito, D. H. A., Silveira, E. R., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177748 · Cited by 7
Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein
Ganguly, U., Singh, S., Chakrabarti, S., Saini, A. K., & Saini, R. V. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.11.010 · Cited by 7
Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease RiskPreprint
Han, Y., Teeple, E. A., Shankara, S., Sadeghi, M., Zhu, C., Liu, D., FinnGen, Wang, C., Frau, F., Klinger, K. W., et al. (2020) · medRxiv · doi:10.1101/2020.10.16.20212944 · Cited by 7
Xu, D., Fang, Y., Hu, M., Shen, Y., Li, H., Wei, L., & He, J. (2025) · BMC Neurology · doi:10.1186/s12883-025-04128-1 · Cited by 6
Metadata
- Authors
- Brudek, T.
- Affiliations
- Frederiksberg Hospital (DK)
- Corresponding author
- Brudek, Tomasz
- ORCID
- Brudek, Tomasz
- Venue
- Journal of Parkinson’s Disease
- Publisher
- SAGE Publications
- Published
- 2019-10-08
- Volume
- 9
- Issue
- s2
- Pages
- S331-S344
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- PMC
- PMC6839501
- OpenAlex
- W2980273606
- Cited by
- 139
- References
- 142
- Citations by year
- 2026: 6 · 2025: 23 · 2024: 21 · 2023: 17 · 2022: 32 · 2021: 31 · 2020: 8 · 2019: 1
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Parkinson s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, inflammatory bowel disease, gut-brain axis, alpha-synuclein, Lewy bodies, dopaminergic neuron loss, intestinal inflammation, gut microbiota, glial activation, inflammatory cytokines, intestinal infection, IBD treatment, disease risk
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Parkinson Disease, Inflammatory Bowel Diseases, Enteric Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.